Literature DB >> 11792470

The possible role of cerebrospinal fluid adenosine deaminase activity in the diagnosis of tuberculous meningitis in adults.

Sang-Ho Choi1, Yang Soo Kim, In-Gyu Bae, Jin-Won Chung, Mi Suk Lee, Jae Myung Kang, Jiso Ryu, Jun-Hee Woo.   

Abstract

We studied an adenosine deaminase (ADA) activity in the cerebrospinal fluid (CSF) of 182 patients with meningitis. The patients were subdivided into four groups, (1) 36 cases of tuberculous meningitis; (2) 130 cases of viral or aseptic meningitis; (3) nine cases of bacterial meningitis; (4) seven cases of cryptococcal meningitis. Mean+/-S.D. ADA activity was 12.76+/-7.53 U/l in group 1; 2.58+/-2.37 U/l in group 2; 7.38+/-3.27 U/l in group 3; 7.42+/-4.38 U/l in group 4. Comparing the ADA activity in each group with the other groups, the difference is significant (P<0.001), except between groups 3 and 4. The sensitivity of the test for group 1 compared with group 2 was 0.83 and the specificity was 0.95 when a cut-off value of 7 U/l was used. When group 1 was compared with groups 3 and 4, the sensitivity was 0.58 and the specificity was 0.89 and 0.71 with groups 3 and 4, respectively, when a cut-off value of 10 U/l was used. Values >15 U/l were not observed in any of the non-tuberculous meningitis patients; therefore, ADA activity >15 U/l could be a strong indication of tuberculous meningitis. We conclude that a determination of CSF ADA can aid in the early differential diagnosis of tuberculous meningitis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11792470     DOI: 10.1016/s0303-8467(01)00159-7

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  12 in total

1.  A Five Years Study of Tuberculous Meningitis in Iran.

Authors:  Massoud Hajia; Ali Akbar Amirzargar; Mina Nazari; Neda Razavi Davodi; Morteza Karami Zarandi
Journal:  Iran J Pathol       Date:  2015

2.  Purine nucleoside phosphorylase activity in rat cerebrospinal fluid.

Authors:  Rafael Guimarães Silva; Diógenes Santiago Santos; Luiz Augusto Basso; Jean Pierre Oses; Susana Wofchuk; Luis Valmor Cruz Portela; Diogo Onofre Souza
Journal:  Neurochem Res       Date:  2004-10       Impact factor: 3.996

3.  Approach to the Diagnosis and Management of Tuberculous Meningitis.

Authors:  Scott W. Sinner; Allan R. Tunkel
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.725

4.  Preliminary report of directly observed treatment, short course in tuberculous meningitis.

Authors:  Thomas Iype; Sinchu Chacko; Sivadasan Raghavan; Robert Mathew; Madhusudanan Mohan
Journal:  Ann Indian Acad Neurol       Date:  2010-01       Impact factor: 1.383

Review 5.  Central nervous system tuberculosis: pathogenesis and clinical aspects.

Authors:  R Bryan Rock; Michael Olin; Cristina A Baker; Thomas W Molitor; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

6.  Determination of serum adenosine deaminase and xanthine oxidase levels in patients with crimean-congo hemorrhagic fever.

Authors:  V Kenan Celik; Ismail Sari; Aynur Engin; Yildiz Gürsel; Hüseyin Aydin; Sevtap Bakir
Journal:  Clinics (Sao Paulo)       Date:  2010-07       Impact factor: 2.365

7.  Predictive performance of serum procalcitonin for the diagnosis of bacterial meningitis after neurosurgery.

Authors:  Seong-Ho Choi; Sang-Ho Choi
Journal:  Infect Chemother       Date:  2013-09-27

8.  Predictive Role of ADA in Bronchoalveolar Lavage Fluid in Making the Diagnosis of Pulmonary Tuberculosis.

Authors:  Fariba Binesh; Abolhassan Halvani
Journal:  Pulm Med       Date:  2013-12-24

9.  Serum and cerebrospinal fluid neuron-specific enolase for diagnosis of tuberculous meningitis.

Authors:  Tae-Jin Song; Young-Chul Choi; Kyung-Yul Lee; Won-Joo Kim
Journal:  Yonsei Med J       Date:  2012-11-01       Impact factor: 2.759

10.  Directly observed treatment, short course in tuberculous meningitis: Indian perspective.

Authors:  Shri Ram Sharma; Kyrshang G Lynrah; Nalini Sharma; Monaliza Lyngdoh
Journal:  Ann Indian Acad Neurol       Date:  2013-01       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.